- More than 11,000 bottles of bisoprolol-HCTZ were recalled for cross contamination.
- Affected lots expire in November 2025 or May 2026; contact your pharmacist for a replacement.
- Classified as Class III, the recall is low risk, and no related illnesses have been reported.
The U.S. Food and Drug Administration (FDA) just announced a recall of 11,136 bottles of blood pressure medication sold nationwide due to cross contamination.
The 2.5-milligram and 6.25-milligram medications affected are bisoprolol fumarate and hydrochlorothiazide tablets distributed in 30-count, 100-count and 500-count bottles. Manufactured by Glenmark Pharmaceuticals Limited, the recalled medications include lot codes “17232401” or “17240974” and expiration dates of “11/2025” or “05/2026.”
Check your blood pressure medication. If it matches the recall information, contact your prescriber or pharmacist for a replacement. The recall was issued because tested samples showed traces of ezetimibe, a drug used to treat high cholesterol. The recall has been classified as Class III, meaning the recalled pills are “not likely to cause adverse health consequences.”
No illnesses or reactions have been linked to this recall. Contact a healthcare provider if you have any concerns. For questions, call the FDA at 1-888-INFO-FDA (1-888-463-6332).